GEN Exclusives

More »

GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

President Bush's recent signing into law of the Genetic Information Nondiscrimination Act (GINA) is not only a victory for individuals but for biotech and pharmaceutical companies as well. GINA is the first and only federal legislation that will provide protection against discrimination based on an individual's genetic information in health insurance coverage and employment settings.


During this week's GEN podcast, Sharon Terry, from the Genetic Alliance, discusses how GINA will allow the promise of genetic testing and disease management and prevention to be more fully realized. She explores both the implications of GINA's passage for companies carrying out biotech or pharmaceutical research and the opportunities that GINA opens up for these companies. Terry also explains how the overall U.S. healthcare system and companies specifically involved in the development of personalized medicine will be impacted by GINA.

Sharon Terry, MA –President and CEO, Genetic Alliance Sharon is President and CEO of the Genetic Alliance, a network transforming health by promoting an environment of openness centered on the health of individuals, families and communities. She is the founding Executive Director of PXE International, a research advocacy organization for the genetic condition pseudoxanthoma elasticum (PXE). Following the diagnosis of their two children with pseudoxanthoma elasticum (PXE) in 1994, Sharon, a former college chaplain, and her husband, Patrick, founded and built a dynamic organization that fosters ethical research and policies and provides support and information to members and the public. She is at the forefront of consumer participation in genetics research, services and policy and serves as a member of many of the major governmental advisory committees on medical research, including liaison to the Secretary’s Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children and the National Advisory Council for Human Genome Research, NHGRI, NIH. She serves on the boards of the Biotechnology Institute, DNA Direct, National Coalition of Health Professional Education in Genetics, and the Coalition for 21st Century Medicine. She is on the steering committees of Genetic Association Information Network of NHGRI, the CETT program, the EGAPP Stakeholders Group and the Google Health Advisory Board. She is the chair of the Coalition for Genetic Fairness that was instrumental in the passage of the Genetic Information Nondiscrimination Act. She is a member of the IOM Roundtable on Translating Genomic-Based Research for Health. She is chair of the Social Issues Committee of American Society of Human Genetics. In 2005, she received an honorary doctorate from Iona College for her work in community engagement and haplotype mapping, and in 2007 received the first Patient Service Award from the UNC Institute for Pharmacogenomics and Individualized Therapy. Ms. Terry is a co-founder of the Genetic Alliance Biobank. It is a centralized biological and data [consent/clinical/environmental] repository catalyzing translational genomic research on rare genetic diseases. The BioBank works in partnership with academic and industrial collaborators to develop novel diagnostics and therapeutics to better understand and treat these diseases. Along with the other co-inventors of the gene associated with PXE (ABCC6), she holds the patent for the invention. She co-directs a 33-lab research consortium and manages 52 offices worldwide for PXE International.


Add a comment

  • Add a comment

  • Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?